Evidence map›Paper›PMID 30069897›Full record

Observational studyBritish journal of clinical pharmacology2018

Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.

G Latkovskis, E Makarova, M Mazule, L Bondare, D Hartmane, H Cirule, S Grinberga, A Erglis, E Liepinsh, M Dambrova

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Trimethylamine-Annals of medicine · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Loop Diuretics Inhibit Renal Excretion of TrimethylamineJACC. Basic to translational science · 2021
    Article
  13. Article
  14. Observational
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

G LatkovskisInstitute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia.ORCID 0000-0002-1322-7920
E MakarovaLatvian Institute of Organic Synthesis, Riga, Latvia.
M MazulePauls Stradins Clinical University Hospital, Riga, Latvia.
L BondarePauls Stradins Clinical University Hospital, Riga, Latvia.
D HartmaneLatvian Institute of Organic Synthesis, Riga, Latvia.
H CiruleLatvian Institute of Organic Synthesis, Riga, Latvia.
S GrinbergaLatvian Institute of Organic Synthesis, Riga, Latvia.
A ErglisInstitute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia.
E LiepinshLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0003-2213-8337
M DambrovaLatvian Institute of Organic Synthesis, Riga, Latvia.ORCID 0000-0002-1739-0928
Latvijas Organiskās Sintēzes Institūts · LVPauls Stradiņš Clinical University Hospital · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTrimethylamine-N-oxide (TMAO) is a novel cardiovascular risk marker. We explored the association of commonly used cardiovascular medications with TMAO levels in patients and validated the identified associations in mice.

methodsDetailed history of drug treatment was recorded in 300 patients with cardiovascular disease without diabetes in an observational, cross-sectional study. Animal study was performed in CD1 mice.

resultsMedian plasma TMAO (interquartile range) level was 2.144 (1.570-3.104) μmol l

conclusionsLoop diuretics increased plasma TMAO concentration by decreasing its urinary excretion rate. Loop diuretic use should be considered a potential confounder in TMAO studies.

Indexed as

AgedAnimalsBiomarkersCardiovascular AgentsCardiovascular DiseasesCross-Sectional StudiesFemaleHeartHumansKidneyLiverMaleMethylaminesMiceMiddle AgedSodium Potassium Chloride Symporter InhibitorsBiomarkersCardiovascular AgentsMethylaminesSodium Potassium Chloride Symporter Inhibitorstrimethyloxaminebiomarkerscardiovascular pharmacologyloop diureticstrimethylamine-N-oxide

Identifiers

PMID30069897
PMCPMC6177719
OpenAlexW2887902947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.